EP3766916
Ný lípíð og lípíð-nanóagnasamsetningar til dreifingar á kjarnsýrum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.6.2015EP published:
28.9.2022EP application number:
20195502.8
EP translation filed:
12.12.2022Grant published:
15.1.2023EPO information:
European Patent Register
Max expiry date:
4.6.2035Expiry date:
4.6.2026Next due date:
30.6.2026
Title in English:
NOVEL LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDSLanguage of the patent:
English
Timeline
Today
5.6.2015EP application
28.9.2022EP Publication
12.12.2022Translation submitted
15.1.2023Registration published
4.6.2026Expires
Owner
Name:
Acuitas Therapeutics Inc.Address:
6190 Agronomy Road Suite 402 University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5, CA
Inventor
Name:
ANSELL, Steven, M.Address:
Vancouver, British Columbia V6J 1W5, CA
Name:
DU, XinyaoAddress:
Richmond, British Columbia V7A 2M1, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462016839 PDate:
25.6.2014Country:
US
Classification
Categories:
C08G 65/325
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 24.5.2023
Expires: 4.6.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 31.5.2024
Expires: 4.6.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 2.6.2025
Expires: 4.6.2026
Payer: Árnason Faktor ehf.